메뉴 건너뛰기




Volumn 12, Issue 1, 2009, Pages 37-42

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)

Author keywords

Neoadjuvant chemotherapy; S 1; Scirrhous gastric cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; TS 1; UNCLASSIFIED DRUG;

EID: 65449119562     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-008-0496-1     Document Type: Article
Times cited : (73)

References (10)
  • 2
    • 0034072591 scopus 로고    scopus 로고
    • Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin
    • O. Maeda H. Iwase N. Mamiya M. Nakamura T. Mizuno Y. Nishio 2000 A case of scirrhous cancer of the stomach which survived for more than 5 years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin Intern Med 9 239 244 (Pubitemid 30204917)
    • (2000) Internal Medicine , vol.39 , Issue.3 , pp. 239-244
    • Maeda, O.1    Iwase, H.2    Mamiya, N.3    Nakamura, M.4    Mizuno, T.5    Nishio, Y.6    Ando, T.7    Ina, K.8    Kusugami, K.9
  • 5
    • 18244381054 scopus 로고    scopus 로고
    • Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer
    • DOI 10.1007/s10120-001-8009-5
    • S. Takahashi T. Kinoshita M. Konishi T. Nakagohri K. Inoue M. Ono 2001 Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer Gastric Cancer 4 192 197 (Pubitemid 34201779)
    • (2001) Gastric Cancer , vol.4 , Issue.4 , pp. 192-197
    • Takahashi, S.1    Kinoshita, T.2    Konishi, M.3    Nakagouri, T.4    Inoue, K.5    Ono, M.6    Sugitou, M.7    Ohtsu, A.8    Boku, N.9    Yoshida, S.10
  • 6
    • 0032819756 scopus 로고    scopus 로고
    • An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers
    • DOI 10.1159/000012032
    • K. Sugimachi Y. Maehara N. Horikoshi Y. Shimada Y. Sakata Y. Miyachi 1999 An early phase II study of oral S-1, a newly developed 5-fluorouracil derivation for advanced and recurrent gastrointestinal cancers Oncology 57 202 210 (Pubitemid 29481693)
    • (1999) Oncology , vol.57 , Issue.3 , pp. 202-210
    • Sugimachi, K.1    Maehara, Y.2    Horikoshi, N.3    Shimada, Y.4    Sakata, Y.5    Mitachi, Y.6    Taguchi, T.7
  • 7
    • 0032189218 scopus 로고    scopus 로고
    • Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients
    • DOI 10.1016/S0959-8049(98)00211-1, PII S0959804998002111
    • Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-04 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720 (Pubitemid 28474225)
    • (1998) European Journal of Cancer , vol.34 , Issue.11 , pp. 1715-1720
    • Sakata, Y.1    Ohtsu, A.2    Horikoshi, N.3    Sugimachi, K.4    Mitachi, Y.5    Taguchi, T.6
  • 8
    • 0034029776 scopus 로고    scopus 로고
    • Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer
    • W. Koizumi M. Kurihara S. Nakano K. Hasegawa 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197 (Pubitemid 30189900)
    • (2000) Oncology , vol.58 , Issue.3 , pp. 191-197
    • Koizumi, W.1    Kurihara, M.2    Nakano, S.3    Hasegawa, K.4
  • 10
    • 0003192645 scopus 로고    scopus 로고
    • Japanese classification of gastric carcinoma-second English edition
    • Japanese Gastric Cancer Association.
    • Japanese Gastric Cancer Association. 1998 Japanese classification of gastric carcinoma-second English edition- Gastric Cancer 1 10 24
    • (1998) Gastric Cancer , vol.1 , pp. 10-24


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.